Clinical Trial: Tocilizumab for Relapsing Polychondritis

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional

Official Title: Efficacy of Tocilizumab in a Patient With Relapsing Polychondritis

Brief Summary: This is a study for one patient with severe relapsing polychondritis which has been unresponsive to other more conventional medications including prednisone, methotrexate, anakinra and TNF inhibitors. Tolerability, and efficacy of the drug, Tocilizumab will be monitored by clinical assessment and bloodwork.

Detailed Summary:
Sponsor: McMaster Children's Hospital

Current Primary Outcome: Efficacy of Tocilizumab [ Time Frame: 2 years ]

Inhibition of inflammatory markers Improvement in symptoms and signs


Original Primary Outcome: Same as current

Current Secondary Outcome: Safety of Tocilizumab [ Time Frame: 2 years ]

Monitoring of serum lipids and liver function tests


Original Secondary Outcome: Same as current

Information By: McMaster Children's Hospital

Dates:
Date Received: April 13, 2010
Date Started: May 2010
Date Completion: May 2012
Last Updated: May 12, 2014
Last Verified: May 2014